Stalevo is a combination of Levodopa which gets converted to dopamine, a chemical messenger that controls movement in the brain. Carbidopa manages the breakdown of Levodopa by allowing it to enter the brain for increased dopamine levels and Entacapone maintains the level of levodopa in the blood. All these collective actions provide greater relief from the symptoms of Parkinson’s disease.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Stalevo 125mg+31.25mg+200mg Tablet combines three active ingredients:
Together, these ingredients provide greater relief from Parkinson's disease symptoms.
Treatment of adult patients with Parkinson's disease experiencing end-of-dose motor fluctuations not stabilized on levodopa/DDC inhibitor treatment.
Adults:
Transferring Patients to Stalevo:
From Levodopa/DDC Inhibitor (Carbidopa or Benserazide) and Entacapone:
From Levodopa/Benserazide and Entacapone:
For Patients Not Currently Treated with Entacapone:
Dose Adjustment During Treatment:
Discontinuation of Stalevo:
Severe hepatic impairment, narrow-angle glaucoma, pheochromocytoma, MAO inhibitors, history of NMS, or hypersensitivity to components.
Store in a cool and dry place away from sunlight
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.